Education
About Us
Working with TipRanks
Follow Us
Oxford Sciences Innovation plc Insider Profile
4 Followers
Oxford Sciences Innovation plc, Ten Percent Owner at Barinthus Biotherapeutics, holds 4.96M shares in PepGen Inc. (Ticker: PEPG), holds 8.80M shares in Barinthus Biotherapeutics (Ticker: BRNS). Most recently, Oxford Sciences Innovation plc Bought ― shares of PepGen Inc. on Oct 01, 2025 for an estimated value of $640.00K.
Oxford Sciences Innovation plc Barinthus Biotherapeutics (BRNS)Ten Percent Owner
Barinthus Biotherapeutics (BRNS)
Ten Percent Owner
Ranked #75,871 out of 104,058 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-29.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Oxford Sciences Innovation plc holds in companies
Most Profitable Insider Trade
The most profitable trade made by Oxford Sciences Innovation plc
Oxford Sciences Innovation plc's Trading History
Barinthus Biotherapeutics
May 06, 2021
Ten Percent Owner
Uninformative Buy
―
$11.72M
PepGen Inc.
Oct 01, 2025
Former 10% Owner
Informative Buy
640.00K
$24.23M
List of latest transactions for each holding click on a transaction to see Oxford Sciences Innovation plc's performance on stock
You May Also Like
Oxford Sciences Innovation plc insider profile FAQ
What is the percentage of profitable transactions made by Oxford Sciences Innovation plc?
The percentage of profitable transactions made by Oxford Sciences Innovation plc is 50%.
What is the average return per transaction made by Oxford Sciences Innovation plc?
The average return per transaction made by Oxford Sciences Innovation plc is -29.20%.
What stocks does Oxford Sciences Innovation plc hold?
Oxford Sciences Innovation plc holds: BRNS, PEPG stocks.
What was Oxford Sciences Innovation plc’s latest transaction?
Oxford Sciences Innovation plc latest transaction was an Informative Buy of $640.00K.
What was Oxford Sciences Innovation plc's most profitable transaction?
Oxford Sciences Innovation plc’s most profitable transaction was an Informative Buy of PEPG stock on October 1, 2025. The return on the trade was 3.80%.
What is Oxford Sciences Innovation plc's role in Barinthus Biotherapeutics?
Oxford Sciences Innovation plc's role in Barinthus Biotherapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.